title: Current developments in therapeutic and diagnostic strategies for Q fever: glimpses of patent analysis.
abstract: Coxiella burnetii is an infectious and etiological agent responsible for causing Q fever. There are mainly two forms of the Q fever that are chronic and acute. Though the acute type is usually linked with symptoms like pneumonia and hepatitis, the chronic form is shown to have mortality rate of 5%. Percentage of mortality rate might increases from 5% to 25% if left untreated. The present treatments of disease include the recommended dose of drugs and vaccine. Presently, extensive attempt is in progress to find novel therapies to combat the disease. This review is projected to provide a brief introduction of C. burnetii and Q fever while emphasizing therapeutics, prophylactic measures and diagnostic applications based on recent patents prospects.
authors.forename: Rashi
authors.initials: R
authors.lastname: Chauhan
authors.forename: Gulshan
authors.initials: G
authors.lastname: Wadhwa
authors.forename: Sanjeev K
authors.initials: SK
authors.lastname: Sharma
authors.affiliation: Department of Biotechnology, Jaypee Institute of Information Technology, A-10, Sector-62, NOIDA- 201307, Uttar Pradesh, India. ckj522@yahoo.com.
authors.forename: Chakresh K
authors.initials: CK
authors.lastname: Jain
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000627:therapeutic use; D006801:Humans; D010330:Patents as Topic; D011778:Q Fever / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines; D024841:Fluoroquinolones; D004318:Doxycycline